We are looking for an ambitious, independent, and enthusiastic Scientist with experience in Molecular Biology and/or Next Generation Sequencing to join our team in planning, conducting, and optimizing RNA-based diagnostic experiments.
In this multifaceted role, you will help advance our pipeline of designed diagnostic products, solve technical obstacles, test different concepts in the laboratory, read scientific papers, and generate new ideas in collaboration with our innovative R&D team.
The position will be based at the headquarters in Bratislava, Slovakia located at the modern Comenius University Science Park.
Ilkovičova 8, Karlova Ves
From 2 178 EUR/month
The starting salary is €2,178, and it will be increased to €2,420 after the probation period.
full-time
We offer a great career with development opportunities in a highly motivating and professional environment. You may be looking for a new career path or simply looking to contribute to a small, hard-working organization with the ambition to make a difference.
You will be offered the opportunity to spearhead the next ground-breaking diagnostic technologies involving RNA-based spatial biology and next-generation sequencing.
The job will be challenging and rewarding at the same time. You will have world class colleagues, 4–5 weeks of paid holiday, and a salary commensurate to your qualifications.
Education in Biology, Molecular Biology, Biochemistry, Biotechnology, Pharmaceutical Sciences, Organic Chemistry or a related field.
English – Advanced (C1)
Please send the application including your CV AND a cover letter to career@multiplexdx.com.
Your application will be treated in accordance with our policies for processing of personal data and the General Data Protection Regulation of the EU.
Expected date of completion of the selection process
20.6.2025
Marcel Kasanický
Tel.: +421290268316
career@multiplexdx.com
MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).
MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.
Find out more about MultiplexDX on Corporate website, Facebook, LinkedIn, Twitter